HealthyONEHEALTHNCT06896877
Nutritional Status and Emotional Well-being of the Worker-consumer in the Food Supply Chain.
An observational study of Healthy, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.
Trial summary
The study aims to assess the well-being and safety of worker-consumers in the food industry, focusing on nutrition, musculoskeletal disorders, and regulatory policies. It follows a "OneHealth" approach, emphasizing the connection between human, animal, and environmental health. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- How many people
- 40 participants
- Where
- 1 siteItaly
- Study dates
- 20 Jun 2025to 7 Nov 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: healthy workers of food-supply-chain
Who may be able to join
- workers affiliated with the Experimental Center, or indirectly connected to the Experimental Center as part of the food supply chain;
- willingness to undergo specific tests, including nutritional status assessments, quality of life surveys, and emotional-affective well-being evaluations;
- signature of informed consent form.
Who cannot join
- pregnancy: pregnant women will be excluded to prevent physiological changes related to pregnancy from affecting the measurements.
- non-representative special diets: workers following special diets for medical or religious reasons, which may not be representative of the general food supply chain population, will be excluded.
- lack of signed informed consent.
Trial locations and contacts
1 site in 1 country.
Italy1 site
Fondazione Don Carlo Gnocchi, Centro Santa Maria della Provvidenza
Roma, RM, 00166
About this study
Official title: Assessment of the Nutritional Status and Emotional Well-being of the Worker-consumer in the Food Supply Chain.
The study aims to assess the well-being and safety of worker-consumers in the food industry, focusing on nutrition, musculoskeletal disorders, and regulatory policies. It follows a "OneHealth" approach, emphasizing the connection between human, animal, and environmental health. The research evaluates the nutritional status of workers in the food-supply chain, analyzing food consumption in both workplace and domestic settings to identify deficiencies or excesses. Through clinical, nutritional, and psychological assessments-including oxidative stress levels, serotonin, quality of life, and emotional well-being-the study seeks to identify high-risk groups and gender differences, providing data-driven insights for personalized dietary recommendations and targeted interventions. Findings will contribute to national policies for improved workforce well-being, supporting best practices and interventions to enhance health, safety, and productivity in the agri-food sector. The results will serve as the foundation for specific guidelines that strengthen the sector's sustainability and regulatory clarity.
Read the detailed description
The study aims to assess, key health parameters in worker-consumers within the food-supply chain. The assessment will be performed during a single visit, assessing:
- the nutritional status of workers: measuring participants' nutritional status to identify potential deficiencies or excesses.
- biological parameters involved in stress: i) the systemic oxidative stress and serotonin levels to evaluate the potential imbalance between pro-oxidant and antioxidant; ii) the serotonin serum levels to analyze the circadian rhythm regulation and satiety perception.
- the quality of life and emotional well-being: using online surveys and validated clinical assessment scales, the study will determine participants' quality of life, with a focus on psychological, physical, and social factors, aiming to identify potential work-related challenges in the food-supply chain.
Secondary Objectives Identification of risk groups: based on nutritional assessments and oxidative stress levels, identifying worker groups at higher risk of developing health conditions due to poor dietary habits or exposure to stress factors.
Analysis of gender differences: Investigating potential gender-based variations in nutritional status, oxidative stress levels, and quality of life, to determine whether specific dietary or health recommendations are needed for men and women.
This study is designed as an exploratory investigation aimed at comparing two groups of individuals with distinct dietary habits and lifestyle patterns, particularly focusing on sedentary workers versus non-sedentary workers engaged in physically demanding tasks.
The number of worker enrolled will be 40 (20 sedentary workers vs 20 non sedentary workers). The sample size has been determined based on existing literature evidence, utilizing phase angle (Di Vincenzo, 2011) and bioelectrical impedance vector analysis (BIVA) (Campa, 2020) as key reference parameters. Statistical power analysis was conducted using G*Power (v.3.1.9.7), employing a two-tailed independent samples t-test, with a significance level (α) set at 0.05 and 80% statistical power.
Effect size estimates (Cohen's d) were as follows: Fat Mass (FM): 0.81 (estimated power 70.1% with 20 participants per group), Fat-Free Mass (FFM): 1.30 (power >95% with 20 participants per group), BIVA Vector Length (VL): 2.06 (power 80% with only 5 participants per group). The selected sample size is sufficient to detect significant differences in FFM and VL, while for FM, the statistical power remains slightly below 80%.
- Conditions
- Healthy
- Keywords
- food supply chain worker, nutritional status, quality of life
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Healthy worker | Participants will be healthy worker of the food-supply chain |
What is being measured
The primary outcome is the main question the study is designed to answer.
The difference in the bioimpedance vectors between two groups of patients (active workers versus sedentary workers), according to BIVA
The difference in bioimpedance vectors between two groups of patients (active workers vs. sedentary workers) will be analyzed using Bioelectrical Impedance Vector Analysis (BIVA).
In BIVA, the Resistance (Rz) and Reactance (Xc) of each subject, standardized by height (in meters), are plotted on an Rz-Xc graph, forming a bioimpedance vector that can be visualized and analyzed.
Measurements will be obtained through Bioelectrical Impedance Analysis (BIA), providing raw data on Resistance (Rz) and Reactance (Xc), which reflect an individual's hydration status and body composition. The differences in bioimpedance vectors between the two groups (active vs. sedentary workers) will be assessed.
Measured: baseline
Secondary outcomes (38)
Weight in kilograms
It is a measure of body mass weight expressed in Kg
Measured: baseline
Height in meters
It is a measure of body height expressed in meters
Measured: baseline
Body mass Index in kg/(m^2)
It is a measure which combines the height and weight values to report Body Mass Index (BMI) expressed in kg/m²; this parameter is valid for adult men and women. World Health Organization (WHO) defined the following cut-offs for BMI corresponding to nutritional status: i. underweight <18.5; ii. normal 18.50 - 24.99; iii.overweight ≥ 25; iv. obese ≥ 30.
Measured: baseline
Waist circumferences expressed in cm
Measures of waist circumferences expressed in cm.
Measured: baseline
Hips circumferences expressed in cm
Measures of hips circumferences expressed in cm.
Measured: baseline
Waist-Hips Ratio (WHR)
The waist-hip ratio or waist-to-hip ratio (WHR) is the dimensionless ratio of the circumference of the waist to that of the hips. This is calculated as waist measurement divided by hip measurement (W⁄H). WHR is used as a measurement of obesity, which in turn is a possible indicator of other more serious health conditions. The WHO states that abdominal obesity is defined as a waist-hip ratio above 0.90 for males and above 0.85 for females.
Measured: baseline
Arm circumferences expressed in cm
Measures of arm circumferences expressed in cm.
Measured: baseline
Calf circumferences expressed in cm
Measures of calf circumferences expressed in cm.
Measured: baseline
Tissue hydration expressed in percentage from Bioelectrical Impedance Analysis (BIA).
It provides the actual hydration values, i.e. the percentage content of fluids (Total Body Water, TBW) in the Lean Mass (Fat-Free Mass, FFM) from Bioelectrical Impedance Analysis (BIA). The values expressed in percentages (% TBW/FFM) allow immediate recognition of normo-physiological states (from 72.7 to 74.3%); any alterations towards congestion are represented with values between 74.4% - 81%, while alterations towards dehydration are identified with values between 72.6%-70%.
Measured: baseline
Nutritional index (mg 24h/height in meters) from Bioelectrical Impedance Analysis (BIA).
Protein/energy nutrition assessment scale derived from Bioelectrical Impedance Analysis (BIA).. Creatinine excretion (Ucr/24h) is estimated by analysing the amount of cell mass detected by the sensor. The result is normalised to the subject's height and classified using the vector impedance technique into four ranges. The colour graphic representation offers simple and immediate identification of altered states of energy and/or protein malnutrition.
Measured: baseline
Resistance (Rz) from Bioelectrical Impedance Analysis (BIA).
Resistance (Rz) is a parameter measured through Bioelectrical Impedance Analysis (BIA), reflecting the opposition of body tissues to the flow of an alternating electrical current. It is primarily influenced by the amount of total body water (TBW) and Fat-Free Mass (FFM).
Measured: baseline
Reactance (Xc) from Bioelectrical Impedance Analysis (BIA).
Reactance (Xc) is a parameter measured through Bioelectrical Impedance Analysis (BIA), representing the capacitive properties of cell membranes and tissues. It reflects cell membrane integrity, body cell mass (BCM), and overall cellular health.
Measured: baseline
Phase Angle (PhA) from Bioelectrical Impedance Analysis (BIA).
Phase Angle (PhA) is a parameter derived from Bioelectrical Impedance Analysis (BIA), calculated as the arctangent of reactance (Xc) to resistance (Rz). It serves as a key indicator of cell membrane integrity, cellular health, and overall nutritional status. A higher PhA is generally associated with better cellular function and nutritional status, while a lower PA may indicate malnutrition or impaired health. The phase angle expresses the proportion between intra- and extracellular spaces, describes properties about the quality of the cell and is used in the clinic as a prognostic index for chronic diseases. In a healthy adult subject, the normal value of phase angle is between 5 and 7 degrees.
Measured: baseline
Total Body Water (TBW) from Bioelectrical Impedance Analysis (BIA).
Total Body Water (TBW) represents the total amount of water present in the body, including both intracellular water (ICW) and extracellular water (ECW). It is measured using Bioelectrical Impedance Analysis (BIA) and expressed in liters or as a percentage of body weight. TBW is a key parameter for evaluating hydration status and body composition.
Measured: baseline
Fat Free Mass (FFM) from Bioelectrical Impedance Analysis (BIA).
Fat-Free Mass (FFM) refers to the total mass of all body components excluding fat, including muscle, bone, water, and other lean tissues. It is measured using Bioelectrical Impedance Analysis (BIA) and expressed in kilograms or as a percentage of body weight. FFM is a key indicator of muscle mass and overall body composition. Lean Mass is the compartment containing everything that is not body fat: it includes the skeleton, about 73% of body fluids, muscles, skin and organs. Good fitness assumes a FFM value of between 77-85% of body weight, depending on the subject's age.
Measured: baseline
Fat Mass (FM) from Bioelectrical Impedance Analysis (BIA).
Fat Mass (FM) represents the total amount of body fat, measured using Bioelectrical Impedance Analysis (BIA). It is expressed in kilograms or as a percentage of body weight. FM is a key parameter for assessing body composition, nutritional status, and metabolic health. Fat Mass (FM) is a compound consisting of glycerol, a substance formed from fatty acids, which is used as an energy concentrate for the muscles. A certain amount of fat is therefore necessary both as an energy reserve and for the proper functioning of life processes. Another small amount, called essential fat, has a protective function for internal organs, but it is important that this accumulation does not exceed physiological limits. Good physical fitness presupposes a FM value of 15-23% of body weight, depending on the subject's age.
Measured: baseline
Body Cell Mass (BCM) from Bioelectrical Impedance Analysis (BIA).
Body Cell Mass (BCM) represents the metabolically active component of Fat-Free Mass (FFM), including muscle cells, organ tissues, intracellular water, and other metabolically active cells. It is measured using Bioelectrical Impedance Analysis (BIA) and is a key indicator of nutritional status, muscle function, and overall cellular health. It is the metabolically active part of the body that does all the functional work, and the 'engine' of the body in which all major metabolic processes take place: from oxygen consumption, glucose oxidation, to protein synthesis. It is the living and active part of the organism, a compartment that the human body should be endowed with in abundance.
Measured: baseline
Skeletal Muscle Mass from Bioelectrical Impedance Analysis (BIA).
Skeletal Muscle Mass (SMM) represents the total weight of skeletal muscles in the body, measured using Bioelectrical Impedance Analysis (BIA). It is expressed in kilograms or as a percentage of body weight and serves as a key indicator of muscle health, physical strength, and nutritional status. Skeletal Muscle Mass (SMM) accounts for about 70 % of the total muscle mass (MM).
Measured: baseline
Appendicular Skeletal Muscle Mass (ASMM) from Bioelectrical Impedance Analysis (BIA).
Appendicular Muscle Mass (AMM) refers to the total muscle mass of the arms and legs, measured using Bioelectrical Impedance Analysis (BIA). It is expressed in kilograms or as a percentage of body weight and is a key parameter for evaluating muscle health, strength, and functional capacity. AMM is particularly relevant for assessing conditions such as sarcopenia and age-related muscle loss. It represents 75% of the Skeletal Muscle Mass (SMM) and is defined as the sum of the muscles of the upper and lower limbs. A reduction in ASMM leads to negative health consequences such as weakness, disability, a worsened quality of life.
Measured: baseline
Basal metabolic rate (BMR) from Bioelectrical Impedance Analysis (BIA).
Basal metabolic rate (BMR) will be estimated using Bioelectrical Impedance Analysis (BIA). The estimation will be based on predictive equations integrated into the BIA device, considering factors such as fat-free mass and total body water. Basal Metabolic Rate (BMR) is the energy expenditure of an organism at rest. BMR includes the energy required for vital metabolic functions (respiration, blood circulation, digestion, nervous system activity, etc.).
Measured: baseline
Total Daily Energy Expenditure (TDEE) from Bioelectrical Impedance Analysis (BIA).
Total Daily Energy Expenditure (TDEE) will be estimated using Bioelectrical Impedance Analysis (BIA). TDEE represents the amount of energy expended by the body at rest to sustain vital physiological functions, including circulation, respiration, and cellular metabolism. The estimation will rely on predictive equations integrated into the BIA device, providing an indirect assessment of metabolic activity, considering the basal metabolic rate (BMR) and muscular physical activity (PAL), assuming the expenditure of thermoregulation and thermogenesis as marginal.
Measured: baseline
Concentration of serum serotonin (ng/mL)
Serum Serotonin concentration will be measured by Enzyme Linked Immunosorbent Assay (ELISA) and expressed in ng/mL
Measured: baseline
Blood concentration of haemoglobin (g/dL)
Blood concentration of haemoglobin will be measured with colorimetric method and expressed in g/dL.
Measured: baseline
Blood levels of lymphocyte (cell per microliters or percentage)
Lymphocyte levels in blood, expressed as absolute count (cells per microliter) or percentage of total white blood cells.
Measured: baseline
Concentration of serum albumin (g/dL)
Serum albumin concentration will be analyzed with colorimetric method and expressed in g/dL
Measured: baseline
Concentration of serum total cholesterol (mg/dL)
Serum concentration of total cholesterol levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of HDL cholesterol serum levels (mg/dL)
Serum concentration of High Density Lipoprotein (HDL) cholesterol levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of C-reactive protein (mg/dL)
Serum concentration of C-reactive protein levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of glucose serum levels (mg/dL)
Serum concentration of glucose levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of triglycerides serum levels (mg/dL)
Serum concentration of triglycerides levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of magnesium serum levels (mg/dL)
Serum concentration of magnesium levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of calcium serum levels in mg/dL
Serum concentration of calcium levels measured with colorimetric method and expressed in mg/dL.
Measured: baseline
Concentration of hydroperoxides serum levels (UCARR)
The concentration of hydroperoxides serum levels is measured with dROMs test, a colorimetric method and expressed in UCARR. In the dROMs test the free radicals, primarily hydroperoxides, contained in the biological sample, close to iron, generate alkoxyl and peroxyl radicals, according to the Fenton's reaction. The radicals, reacting with a chromogenic mixture, oxidize it and transform it into a photo-metrically measurable coloured derivative. The values are expressed in arbitrary units (UCARR), 1 UCARR corresponding to 0.08 mg/100 mL of hydrogen peroxide.
Measured: baseline
Concentration of total antioxidant serum levels (µmol/L)
The concentration of total antioxidant serum levels is measured with BAP-Test (Biological Antioxidant Potential). It measures the amount of endogenous and exogenous substances in plasma that have the potential to be antioxidants and can counteract radical species and is reported in µmol/L. In the BAP test, the biological antioxidant potential of plasma barrier is based on the ability of all antioxidants active to re-duce a colored solution of ferric ions (Fe3+) to ferrous ions (Fe2+), resulting a decoloration of the solution that is detectable photometrically
Measured: baseline
Measurement of Oxidative stress Index (dimensionless ratio)
the Oxidative stress Index (OSI index), is a ratio calculated from BAP and dROMs (BAP/dROMs). The antioxidative/oxidative stress ratio was also calculated using the ratio equation: BAP/d-ROMs. According to literature, we named this ratio the OSI index, which is an index of potential antioxidant capacity. The criterion value for the BAP/d-ROMs ratio was set at 7.3. Accordingly, a value lower than 7.3 was defined as an oxidized type and a higher or equal one as a reduced type.
Measured: baseline
Nutritional Risk Index NRI
The Nutritional Risk Index (NRI) is a tool designed to assess a patient's nutritional status and predict the risk of complications associated with malnutrition. It is calculated using the following formula:
NRI = (1.519 × serum albumin [g/L]) + (41.7 × current weight [kg] / usual weight [kg]) The lower the score, the higher the risk. (No risk: NRI > 100- Severe risk: NRI < 83.5 )
Measured: baseline
Prognostic Nutritional Index (PNI)
The Prognostic Nutritional Index (PNI) is a tool used to assess the immunological and nutritional status of patients, particularly in predicting surgical outcomes, cancer prognosis, and postoperative complications.The PNI is calculated using the following formula:
PNI=(10×serum albumin (g/dL))+(0.005×total lymphocyte count per mm^3) The lower the score, the higher the risk.(Normal nutritional status, low risk: PNI > 38; moderate risk: scores between 35 and 38 severe malnutrition, high risk: PNI < 35).
Measured: baseline
Self-reported nutritional, psychological, and lifestyle survey
Participants will complete an online survey including questions on general information, prevalence of medication, supplement, and nutraceutical use, body mass index (BMI), dietary habits, adherence to the Mediterranean diet, eating behavior, symptoms of malnutrition, psychological stress level, physical activity, and musculoskeletal disorders.
Measured: baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2025
- Study start20 Jun 2025
- Primary completion7 Nov 2025
- Study completion7 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by Fondazione Don Carlo Gnocchi ETSThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETS
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Irene Giovanna Aprile, Fondazione Don Carlo Gnocchi ETS
- Investigators
- Irene G Aprile, MD, PhD, Principal investigator, Fondazione Don Carlo Gnocchi ETS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06896877
- Sponsor's protocol ID
- FDG_BRIC_ONEHEALTH
- Acronym
- ONEHEALTH
- Status last verified
- Dec 2025
- First submitted
- 17 Mar 2025
- Last updated
- 11 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.
PubMed 9817120Di Vincenzo O, Marra M, Sammarco R, Speranza E, Cioffi I, Scalfi L. Body composition, segmental bioimpedance phase angle and muscular strength in professional volleyball players compared to a control group. J Sports Med Phys Fitness. 2020 Jun;60(6):870-874. doi: 10.23736/S0022-4707.20.10548-6.
PubMed 32487981Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018 Apr 26;13:757-772. doi: 10.2147/CIA.S158513. eCollection 2018.
PubMed 29731617Campa F, Silva AM, Matias CN, Monteiro CP, Paoli A, Nunes JP, Talluri J, Lukaski H, Toselli S. Body Water Content and Morphological Characteristics Modify Bioimpedance Vector Patterns in Volleyball, Soccer, and Rugby Players. Int J Environ Res Public Health. 2020 Sep 10;17(18):6604. doi: 10.3390/ijerph17186604.
PubMed 32927903Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180-3. doi: 10.1016/j.redox.2015.01.002. Epub 2015 Jan 3.
PubMed 25588755Vassalle C, Vigna L, Bianchi S, Maffei S, Novembrino C, De Giuseppe R, de Liso F, Vannucci A, Tirelli S, Maiavacca R, Bamonti F. A biomarker of oxidative stress as a nontraditional risk factor in obese subjects. Biomark Med. 2013 Aug;7(4):633-9. doi: 10.2217/bmm.13.49.
PubMed 23905900Silva AM. Structural and functional body components in athletic health and performance phenotypes. Eur J Clin Nutr. 2019 Feb;73(2):215-224. doi: 10.1038/s41430-018-0321-9. Epub 2018 Oct 4.
PubMed 30287933Siotto M, Cocco C, Bertoncini C, Guerrini A, Habib V, Antonacci E, Ruco E, Aprile IG. One Health Approach to Nutritional Status and Well-Being in Food Supply Chain Workers: A Study Protocol. Int J Environ Res Public Health. 2026 Jan 11;23(1):99. doi: 10.3390/ijerph23010099.
PubMed 41595893
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of the Nutritional Status and Emotional Well-being of the Worker-consumer in the Food Supply Chain.
- ClinicalTrials.gov ID
- NCT06896877
- Acronym / sponsor ID
- ONEHEALTH / FDG_BRIC_ONEHEALTH
- Conditions
- Healthy
- Keywords
- food supply chain worker, nutritional status, quality of life
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Fondazione Don Carlo Gnocchi ETSUniversity, hospital or other
- Study start
- 20 Jun 2025 (actual)
- Primary completion
- 7 Nov 2025 (actual)
- Study completion
- 7 Nov 2025 (actual)
- First posted
- 26 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study aims to assess the well-being and safety of worker-consumers in the food industry, focusing on nutrition, musculoskeletal disorders, and regulatory policies. It follows a "OneHealth" approach, emphasizing the connection between human, animal, and environmental health. The research evaluates the nutritional status of workers in the food-supply chain, analyzing food consumption in both workplace and domestic settings to identify deficiencies or excesses. Through clinical, nutritional, and psychological assessments-including oxidative stress levels, serotonin, quality of life, and emotional well-being-the study seeks to identify high-risk groups and gender differences, providing data-driven insights for personalized dietary recommendations and targeted interventions. Findings will contribute to national policies for improved workforce well-being, supporting best practices and interventions to enhance health, safety, and productivity in the agri-food sector. The results will serve as the foundation for specific guidelines that strengthen the sector's sustainability and regulatory clarity.
Detailed description
The study aims to assess, key health parameters in worker-consumers within the food-supply chain. The assessment will be performed during a single visit, assessing:
- the nutritional status of workers: measuring participants' nutritional status to identify potential deficiencies or excesses.
- biological parameters involved in stress: i) the systemic oxidative stress and serotonin levels to evaluate the potential imbalance between pro-oxidant and antioxidant; ii) the serotonin serum levels to analyze the circadian rhythm regulation and satiety perception.
- the quality of life and emotional well-being: using online surveys and validated clinical assessment scales, the study will determine participants' quality of life, with a focus on psychological, physical, and social factors, aiming to identify potential work-related challenges in the food-supply chain.
Secondary Objectives Identification of risk groups: based on nutritional assessments and oxidative stress levels, identifying worker groups at higher risk of developing health conditions due to poor dietary habits or exposure to stress factors.
Analysis of gender differences: Investigating potential gender-based variations in nutritional status, oxidative stress levels, and quality of life, to determine whether specific dietary or health recommendations are needed for men and women.
This study is designed as an exploratory investigation aimed at comparing two groups of individuals with distinct dietary habits and lifestyle patterns, particularly focusing on sedentary workers versus non-sedentary workers engaged in physically demanding tasks.
The number of worker enrolled will be 40 (20 sedentary workers vs 20 non sedentary workers). The sample size has been determined based on existing literature evidence, utilizing phase angle (Di Vincenzo, 2011) and bioelectrical impedance vector analysis (BIVA) (Campa, 2020) as key reference parameters. Statistical power analysis was conducted using G*Power (v.3.1.9.7), employing a two-tailed independent samples t-test, with a significance level (α) set at 0.05 and 80% statistical power.
Effect size estimates (Cohen's d) were as follows: Fat Mass (FM): 0.81 (estimated power 70.1% with 20 participants per group), Fat-Free Mass (FFM): 1.30 (power >95% with 20 participants per group), BIVA Vector Length (VL): 2.06 (power 80% with only 5 participants per group). The selected sample size is sufficient to detect significant differences in FFM and VL, while for FM, the statistical power remains slightly below 80%.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Healthy worker | – | –Participants will be healthy worker of the food-supply chain |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- healthy workers of food-supply-chain
Key inclusion criteria (3 listed)
- workers affiliated with the Experimental Center, or indirectly connected to the Experimental Center as part of the food supply chain;
- willingness to undergo specific tests, including nutritional status assessments, quality of life surveys, and emotional-affective well-being evaluations;
- signature of informed consent form.
Key exclusion criteria (3 listed)
- pregnancy: pregnant women will be excluded to prevent physiological changes related to pregnancy from affecting the measurements.
- non-representative special diets: workers following special diets for medical or religious reasons, which may not be representative of the general food supply chain population, will be excluded.
- lack of signed informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The difference in the bioimpedance vectors between two groups of patients (active workers versus sedentary workers), according to BIVA
Time frame: baseline
The difference in bioimpedance vectors between two groups of patients (active workers vs. sedentary workers) will be analyzed using Bioelectrical Impedance Vector Analysis (BIVA). In BIVA, the Resistance (Rz) and Reactance (Xc) of each subject, standardized by height (in meters), are plotted on an Rz-Xc graph, forming a bioimpedance vector that can be visualized and analyzed. Measurements will be obtained through Bioelectrical Impedance Analysis (BIA), providing raw data on Resistance (Rz) and Reactance (Xc), which reflect an individual's hydration status and body composition. The differences in bioimpedance vectors between the two groups (active vs. sedentary workers) will be assessed.
38 secondary outcomes
Weight in kilograms
Time frame: baseline
Height in meters
Time frame: baseline
Body mass Index in kg/(m^2)
Time frame: baseline
Waist circumferences expressed in cm
Time frame: baseline
Hips circumferences expressed in cm
Time frame: baseline
Waist-Hips Ratio (WHR)
Time frame: baseline
Arm circumferences expressed in cm
Time frame: baseline
Calf circumferences expressed in cm
Time frame: baseline
Tissue hydration expressed in percentage from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Nutritional index (mg 24h/height in meters) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Resistance (Rz) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Reactance (Xc) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Phase Angle (PhA) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Total Body Water (TBW) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Fat Free Mass (FFM) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Fat Mass (FM) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Body Cell Mass (BCM) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Skeletal Muscle Mass from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Appendicular Skeletal Muscle Mass (ASMM) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Basal metabolic rate (BMR) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Total Daily Energy Expenditure (TDEE) from Bioelectrical Impedance Analysis (BIA).
Time frame: baseline
Concentration of serum serotonin (ng/mL)
Time frame: baseline
Blood concentration of haemoglobin (g/dL)
Time frame: baseline
Blood levels of lymphocyte (cell per microliters or percentage)
Time frame: baseline
Concentration of serum albumin (g/dL)
Time frame: baseline
Concentration of serum total cholesterol (mg/dL)
Time frame: baseline
Concentration of HDL cholesterol serum levels (mg/dL)
Time frame: baseline
Concentration of C-reactive protein (mg/dL)
Time frame: baseline
Concentration of glucose serum levels (mg/dL)
Time frame: baseline
Concentration of triglycerides serum levels (mg/dL)
Time frame: baseline
Concentration of magnesium serum levels (mg/dL)
Time frame: baseline
Concentration of calcium serum levels in mg/dL
Time frame: baseline
Concentration of hydroperoxides serum levels (UCARR)
Time frame: baseline
Concentration of total antioxidant serum levels (µmol/L)
Time frame: baseline
Measurement of Oxidative stress Index (dimensionless ratio)
Time frame: baseline
Nutritional Risk Index NRI
Time frame: baseline
Prognostic Nutritional Index (PNI)
Time frame: baseline
Self-reported nutritional, psychological, and lifestyle survey
Time frame: baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2025.
- Background: PubMed 9817120Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol. 1998 Nov;51(11):1025-36. doi: 10.1016/s0895-4356(98)00094-8.
- Background: PubMed 32487981Di Vincenzo O, Marra M, Sammarco R, Speranza E, Cioffi I, Scalfi L. Body composition, segmental bioimpedance phase angle and muscular strength in professional volleyball players compared to a control group. J Sports Med Phys Fitness. 2020 Jun;60(6):870-874. doi: 10.23736/S0022-4707.20.10548-6.
- Background: PubMed 29731617Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D, Abete P. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018 Apr 26;13:757-772. doi: 10.2147/CIA.S158513. eCollection 2018.
- Background: PubMed 32927903Campa F, Silva AM, Matias CN, Monteiro CP, Paoli A, Nunes JP, Talluri J, Lukaski H, Toselli S. Body Water Content and Morphological Characteristics Modify Bioimpedance Vector Patterns in Volleyball, Soccer, and Rugby Players. Int J Environ Res Public Health. 2020 Sep 10;17(18):6604. doi: 10.3390/ijerph17186604.
- Background: PubMed 25588755Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015;4:180-3. doi: 10.1016/j.redox.2015.01.002. Epub 2015 Jan 3.
- Background: PubMed 23905900Vassalle C, Vigna L, Bianchi S, Maffei S, Novembrino C, De Giuseppe R, de Liso F, Vannucci A, Tirelli S, Maiavacca R, Bamonti F. A biomarker of oxidative stress as a nontraditional risk factor in obese subjects. Biomark Med. 2013 Aug;7(4):633-9. doi: 10.2217/bmm.13.49.
- Background: PubMed 30287933Silva AM. Structural and functional body components in athletic health and performance phenotypes. Eur J Clin Nutr. 2019 Feb;73(2):215-224. doi: 10.1038/s41430-018-0321-9. Epub 2018 Oct 4.
- Derived from this study: PubMed 41595893Siotto M, Cocco C, Bertoncini C, Guerrini A, Habib V, Antonacci E, Ruco E, Aprile IG. One Health Approach to Nutritional Status and Well-Being in Food Supply Chain Workers: A Study Protocol. Int J Environ Res Public Health. 2026 Jan 11;23(1):99. doi: 10.3390/ijerph23010099.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Irene G Aprile, MD, PhD principal investigator
Fondazione Don Carlo Gnocchi ETS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The difference in the bioimpedance vectors between two groups of patients (active workers versus sedentary workers), according to BIVA (time frame: baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06896877, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2025.